HHS to fund $4.9M ibogaine research for PTSD
PBS NewsHour reports: The Trump administration will invest up to $4.9 million over five years in ibogaine research, with Mark Cuban's help, while senators warn against betting on unproven health trials.
Health · 9 sources · November 13, 2026 at 4:35 PM
The Trump administration announced up to $4.9 million in funding over five years to research ibogaine, a controversial psychedelic drug, as a potential treatment for PTSD and addiction. Federal officials said the drug has drawn interest from veterans, conservative lawmakers, and podcasters aligned with President Trump. Endpoints News reports Mark Cuban is involved in the effort. Separately, RFK Jr.'s HHS is allowing pharmacies to sell six unproven peptides with no regulatory oversight, according to Fortune. Senators Alsobrooks and Wyden have urged HHS to act, warning against betting on unproven health trials.
“Alsobrooks, Wyden Warn Against Betting on Health Trials; Urge Action from HHS The Washington Informer”
Sources
- STAT+: Enforcement of stringent Medicaid work requirements delayed for six monthsSTAT · tier 3 · November 13, 2026 at 5:21 PM
- Trump Administration Lets States Delay New Medicaid Work RulesBloomberg · tier 1 · November 13, 2026 at 4:35 PM
- Alsobrooks, Wyden Warn Against Betting on Health Trials; Urge Action from HHSThe Washington Informer · tier 2 · November 13, 2026 at 11:34 AM
- RFK Jr.’s HHS lets pharmacies sell 6 unproven peptides — and no regulator will check what’s in themFortune · tier 2 · November 13, 2026 at 11:17 AM
- HHS plans funding for research into ibogaine for PTSDSTAT · tier 2 · November 13, 2026 at 10:26 AM
- STAT+: HHS plans funding for research into ibogaine for PTSDSTAT · tier 3 · November 13, 2026 at 10:25 AM
- HHS planning to invest $4.9M over 5 years for Ibogaine researchKVUE · tier 2 · November 13, 2026 at 8:28 AM
- Trump administration invests $4.9 million to research psychedelic as PTSD treatmentPhillyVoice · tier 2 · November 12, 2026 at 5:34 PM
- Trump Officials Will Fund New Research on Controversial Psychedelic Drug IbogaineMedPage Today · tier 3 · November 12, 2026 at 5:00 PM
- WATCH: Trump administration officials announce PTSD research funding for psychedelic drug ibogainePBS NewsHour · tier 1 · November 12, 2026 at 4:58 PM
- HHS funnels funding and research toward ibogaine and other psychedelics, with Mark Cuban’s helpEndpoints News · tier 2 · November 12, 2026 at 3:09 PM
Timeline
- November 13, 2026 at 4:59 PM — First source: Endpoints News — “HHS funnels funding and research toward ibogaine and other psychedelics, with Mark Cuban’s help”
- November 13, 2026 at 4:59 PM — Added: PBS NewsHour — “WATCH: Trump administration officials announce PTSD research funding for psychedelic drug ibogaine”
- November 13, 2026 at 4:59 PM — Added: MedPage Today — “Trump Officials Will Fund New Research on Controversial Psychedelic Drug Ibogaine”
- November 13, 2026 at 4:59 PM — Added: KVUE — “HHS planning to invest $4.9M over 5 years for Ibogaine research”
- November 13, 2026 at 4:59 PM — Added: STAT — “STAT+: HHS plans funding for research into ibogaine for PTSD”
- November 13, 2026 at 4:59 PM — Added: STAT — “HHS plans funding for research into ibogaine for PTSD”
- November 13, 2026 at 4:59 PM — Added: Fortune — “RFK Jr.’s HHS lets pharmacies sell 6 unproven peptides — and no regulator will check what’s in them”
- November 13, 2026 at 4:59 PM — Added: The Washington Informer — “Alsobrooks, Wyden Warn Against Betting on Health Trials; Urge Action from HHS”
- November 13, 2026 at 5:03 PM — Writer flags: unsupported
- November 13, 2026 at 5:21 PM — Added: Bloomberg — “Trump Administration Lets States Delay New Medicaid Work Rules”
- November 13, 2026 at 5:40 PM — Added: PhillyVoice — “Trump administration invests $4.9 million to research psychedelic as PTSD treatment”
- November 13, 2026 at 5:40 PM — Added: STAT — “STAT+: Enforcement of stringent Medicaid work requirements delayed for six months”